MNSQX
Price
$26.08
Change
-$0.10 (-0.38%)
Updated
Jul 31 closing price
Net Assets
2.58B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

MNSQX vs VSCIX

MNSQX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
MNSQX vs. VSCIX commentary
Aug 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNSQX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. MNSQX (2.58B). VSCIX pays higher dividends than MNSQX: VSCIX (1.23) vs MNSQX (0.38). MNSQX was incepted earlier than VSCIX: MNSQX (7 years) vs VSCIX (29 years). MNSQX (0.76) is less costly to investors than VSCIX (0.03). MNSQX is a more actively managed with annual turnover of: 53.00 vs. VSCIX (17.00). MNSQX has a lower initial minimum investment than VSCIX: MNSQX (1000000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. MNSQX (16.93). VSCIX return over 5 years is better than : 35.13 vs. MNSQX (23.09).
MNSQXVSCIXMNSQX / VSCIX
Total Expense Ratio0.760.032,533%
Annual Report Gross Expense Ratio0.760.032,533%
Fund Existence7 years29 years-
Gain YTD16.79414.591115%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets2.58B189B1%
Annual Yield % from dividends0.381.2331%
Returns for 1 year16.9322.5875%
Returns for 3 years30.2743.4470%
Returns for 5 years23.0935.1366%
Returns for 10 yearsN/A156.07-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
PIEQX22.30-0.17
-0.76%
T. Rowe Price International Eq Index
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv